Title: An update on Cutaneous and Mucocutaneous Leishmaniasis

Date: Wednesday, 18 March 2026

Time: 8:45 AM EDT UTC-04 (The webinar is approximately 90 minutes)

To check your time zone, go to the time and date website: Here

Registration Fee:

Complimentary Members Only Webinar 

You must register to attend.

To ensure timely receipt of the Zoom link, kindly complete your registration for the webinar at least one hour before the scheduled start time.

Cutaneous leishmaniasis (CL) is a vector-borne parasitic infection of growing clinical relevance in travel medicine, global health, and infectious disease practice. With evolving geographic distribution, increasing numbers of returning travelers and immigrants presenting with chronic skin lesions, and a complex treatment landscape, clinicians face important diagnostic and management challenges. 

In this webinar presented by the new Tropical Medicine Interest Group, Drs. Michael Libman and Naomi Aronson provide a practical clinical update on CL — covering epidemiology, clinical recognition, diagnostic approaches, and current treatment strategies, with an emphasis on what practitioners need to know in 2026.

By the end of this webinar, participants will be able to:

1. Recognize and differentiate the clinical presentations of cutaneous leishmaniasis, including atypical features, and apply an appropriate workup based on exposure history, geographic risk, and lesion characteristics.
2. Identify key epidemiological trends — including species-related differences in geographic distribution, disease manifestations, and risk of mucosal progression — to guide clinical risk stratification and counseling for travelers, immigrants, and at-risk population
3. Recognize the methods and availability of current diagnostic method
4. Select and apply current treatment options for CL, including systemic and local therapies, using an evidence-informed framework that accounts for infecting species, lesion characteristics, host factors, and setting-specific drug availability

Webinar Faculty:

Moderators: 

Dr. Eli Schwartz

Dr. Elise O'Connell

Speakers: 

Dr. Naomi E. Aronson

Dr. Michael Libman

CREDIT HOURS

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLCand International Society of Travel Medicine. Amedco LLC is jointly accredited by the AccreditationCouncil for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education(ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education forthe healthcare team.

Professions in scope for this activity are listed below.

Amedco Joint Accreditation Provider Number: 4008163

Physicians

Amedco LLC designates this live activity for a maximum of 1 ACCME AMA PRA Category 1 Credits TM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists & Pharmacy Technicians

Amedco LLC designates this activity for a maximum of 1 ACPE knowledge-based CPE contact hours.

UAN JA4008163-9999-26-033-L01-P | UAN JA4008163-9999-26-033-L01-T UAN JA4008163-9999-26-034-L06-P | UAN JA4008163-9999-26-034-L06-T

NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.

Nurses

Amedco LLC designates this activity for a maximum of 1 ANCC contact hours.

Objectives - After Attending This Program You Should Be Able To
1. Clinicians will gain ability to recognize CL, assess epidemiologic risk, select appropriate diagnostic approaches, and apply current treatment options based on species, lesion characteristics, and patient factors.

Acknowledgement of Financial Commercial Support No financial commercial support was received for this educational activity.

Acknowledgement of In-Kind Commercial Support No in-kind commercial support was received for this educational activity.

Satisfactory Completion Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. You must attend the entire webinar as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5)

All individuals in a position to control the content of CE are listed below.
Name Commercial Interest:Relationship
Naomi Aronson UpToDate, BMJ Best Evidence:Other
Elise Oconnell NA
Kyle Petersen NA
Missy Zagroba NA
Kim Gray NA
Ryan Dixon NA

How to Get Your Certificate
1. Go to istm.cmecertificateonline.com
2. Click on the An update on Cutaneous and Mucocutaneous Leishmaniasis link.
3. Evaluate the meeting.
4. Print, download, or save your certificate for your records.
5. If you lose your certificate, or need help, go to help.cmecertificateonline.com